HOME >> MEDICINE >> NEWS
Antigen targeted in therapy for melanoma also prompts immune response in brain tumor cells

LOS ANGELES (Sept. 24, 2003) A protein fragment that was previously found in melanomas has now been detected in highly aggressive brain tumors called gliomas that take the lives of about 15,000 Americans each year.

This peptide, which the immune system recognizes as an antigen, or foreign invader, appears to be a target for anti-tumor immune therapy, according to studies conducted by researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute and the National Cancer Institute. It also may be useful as a marker that will enable scientists to monitor immune responses in human clinical trials against cancer cells called glioblastoma multiforme (GBM), often referred to as gliomas.

Institute scientists and neurosurgeons have for several years conducted clinical trials using immunotherapy techniques to battle gliomas, removing brain tumor cells and culturing them with immune system cells called dendritic cells in the lab. When the resulting "vaccine" is injected into the patient's bloodstream, the dendritic cells recognize the tumor cells as invaders and "present" them to the antigen-fighting T-lymphocytes, triggering an immune response.

"The outlook for patients who suffer from these highly aggressive tumors has historically been extremely poor, and even conventional treatments such as surgery, chemotherapy and radiation therapy have provided almost no benefit," said Keith L. Black, M.D., neurosurgeon and founder and director of the Institute. "Based on the results of our early studies, the immune system appears to have the potential to destroy glioma cells and contribute to longer periods of patient survival. Unfortunately, the immune system is not very effective on its own. Therefore, we are always looking for new ways to target and boost the immune response."

In mouse and human studies of melanoma, tyrosinase-related protein-2 (TRP-2) has proved to be an excellent target for immunotherapies. This study found that the TRP-2 anti
'"/>

Contact: Sandra Van
sandy@vancommunications.com
1-800-880-2397
Cedars-Sinai Medical Center
24-Sep-2003


Page: 1 2 3

Related medicine news :

1. Tumor-targeted immune cells cure prostate cancer in mice without causing systemic immune suppression
2. Residual tumor cells are a barrier to targeted cancer therapeutics
3. Genetically targeted therapies create opportunities to do business in new ways
4. Screening for genital herpes should be targeted
5. Pap smears, mammography should be targeted at healthy elders, study says
6. Mayo researchers invent targeted imaging probe to aid early Alzheimers diagnosis
7. Physicians have mixed opinions about consumer-targeted pharmaceutical ads
8. Researchers identify leukemia-linked pathway targeted by a new kinase inhibitor
9. NIAMS researchers collaborate to produce targeted immunosuppressant drug
10. Stanford research shows targeted DNA vaccine may reverse autoimmune disease
11. Secret documents reveal how tobacco industry targeted gay men

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/15/2019)... ... March 15, 2019 , ... The National Association of Chain ... controlled substance prescriptions for Schedule II through Schedule VI, which will help prevent opioid ... will become effective January 1, 2021. , NACDS recognizes the leadership of ...
(Date:3/15/2019)... ... March 15, 2019 , ... The National Association of ... to a seven-day supply the initial prescriptions of opioids for acute pain – ... (CDC) guidelines for prescribing opioids. , U.S. Sen. Kirsten Gillibrand (D-NY) and U.S. ...
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... The ... Friday, March 15th at the Bellevue Club in Bellevue, Washington. GBM is short for ... EBCI and its sponsors and partners invite current and past brain cancer patients, survivors, ...
(Date:3/14/2019)... ... 14, 2019 , ... The National University System ... Sanford Harmony —today announced a new partnership with the Alliance for a ... lifelong healthy habits. The partnership will focus on building awareness of the integral ...
(Date:3/14/2019)... Va. (PRWEB) , ... March 14, 2019 , ... Cell ... FDA Approval, **An FDAnews Webinar**, Thursday, March 28, 2019, 1:30 p.m. - 3:00 p.m. ... approving 10 to 20 cell and gene therapy products a year. , That ...
Breaking Medicine News(10 mins):
(Date:3/12/2019)... ... March 13, 2019 , ... The nation's top provider of ... its upcoming workshops. The code to use for obtaining the discount is R3SCT500. , ... therapies having been performed to date. Last year, R3 began its first stem cell ...
(Date:3/12/2019)... ... March 12, 2019 , ... Global Lyme Alliance (GLA), ... research, education and awareness, today announced it has partnered with the state of ... course for physicians and other healthcare professionals. , This Continuing Medical Education ...
(Date:3/12/2019)... ... March 12, 2019 , ... Ventura County Board ... Health Champion at Work award. , Health Champion award recipients are recognized for ... making Ventura County the healthiest county in California. , Guided by a ...
Breaking Medicine Technology:
Cached News: